Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 0781-5801

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 0781-5801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sitagliptin Chemical Structure (Image 01)

Chemical structure of Sitagliptin and Metformin Hydrochloride as depicted in the image, showing the molecular configuration including trifluorophenyl, piperazine, and other characteristic chemical groups along with phosphate and water molecules.*

FDA Label Image

Metformin Chemical Structure (Image 02)

Chemical structure of Sitagliptin and Metformin Hydrochloride active ingredients, showing molecular components including amine and methyl groups along with HCl notation.*

FDA Label Image

Figure 1 (Image 03)

A line graph showing the least squares mean change from baseline over 24 weeks for multiple treatments including placebo, Metformin doses, Sitagliptin doses, and their combinations. The x-axis represents weeks, and the y-axis represents mean change from baseline. Different symbols denote different treatment groups.*

FDA Label Image

Figure 2 (Image 04)

A line graph showing the least squares mean change from baseline in A1C levels over 52 weeks, comparing Sitagliptin 100 mg and Glipizide. The x-axis represents time in weeks, and the y-axis shows the change from baseline. Both treatments show a similar trend of decreased A1C levels that stabilize and slightly increase towards week 52.*

FDA Label Image

Label-1 (Image 05)

Label for Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg film-coated tablets by Sandoz Inc, containing 60 tablets. The label includes dosage details stating each tablet contains 64.25 mg sitagliptin phosphate (50 mg sitagliptin) and 500 mg metformin hydrochloride. It also mentions storage instructions and manufacturer information.*

FDA Label Image

Label-2 (Image 06)

Label for Sitagliptin and Metformin Hydrochloride tablets 50 mg/1000 mg by Sandoz Inc. The film-coated oral tablets are supplied in a package of 60. The label instructs pharmacists to dispense the accompanying medication guide and provides storage and safety information. Manufactured by Sandoz Private Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.